First Patient Dosed in EO2401 Clinical Trial for Adrenal Tumors
source: pixabay.com

First Patient Dosed in EO2401 Clinical Trial for Adrenal Tumors

Early this week, clinical-stage biopharmaceutical company Enterome announced that the first patient was dosed in a Phase 1/2 clinical trial. The SPENCER trial will evaluate EO2401 as a potential treatment…

Continue Reading First Patient Dosed in EO2401 Clinical Trial for Adrenal Tumors

Researchers Find Immunotherapy Drug May Treat Pheochromocytoma

Those diagnosed with paraganglioma-pheochromocytoma, squamous cell carcinoma of the skin (cSCC), adrenocortical carcinoma (ACC), and carcinoma of unknown primary (CUP) may soon have an additional option for treatment. According to…

Continue Reading Researchers Find Immunotherapy Drug May Treat Pheochromocytoma
Close Menu